Why CRISPR technology is still patented - Even after the Nobel Prize winners' patent loss 🧬 Last week, my post about how a simple mistake cost two Nobel Prize winners their European CRISPR ...

How a simple mistake cost two Nobel Prize winners their European CRISPR patents. 🧬 This case serves as a cautionary tale for anyone involved in patent filing, especially scientists: ️ ...

The EU CRISPR patent landscape: a complex battle In the patent field, CRISPR/Cas technology has sparked intense patent battles in Europe, with significant implications for innovation and market ...

In a landmark achievement for both Uganda and the global medical community, the United States Patent and Trademark Office ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...

Partnerships allow Crispr Therapeutics to receive milestones and economic benefits from drug candidate progression while offsetting some of the clinical development costs.

Investing in stocks that aren't performing well can be a good move, but only if there are good reasons to think they will ...

Quinn Emanuel represents the Broad Institute, Massachusetts Institute of Technology and the President and Fellows of Harvard College in a dispute over who was first to invent a CRISPR-Cas9 ...

CRISPR technology has revolutionized genetic testing and disease detection, offering precise, rapid, and cost-effective diagnostic solutions. This gene-editing tool has been adapted for molecular ...

Why are CRISPR companies not OK? Will Robert F. Kennedy Jr. keep his promises if he’s confirmed to lead the Department of Health and Human Services? And how do you pronounce Journavx?

CRISPR-Cas systems are prokaryotic immune systems that confer resistance to foreign genetic elements such as plasmids and phages. CRISPR-Cas systems have been exploited for targeted genome editing ...